Source:http://linkedlifedata.com/resource/pubmed/id/11525268
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2001-8-29
|
pubmed:abstractText |
Prospective studies are not available to address various issues commonly encountered in the management of hypothyroid patients. We have conducted a case-based mail survey of American Thyroid Association (ATA) members and primary care providers (PCP) regarding hypothyroidism management issues. A majority of ATA members and a minority of PCPs used antithyroid antibody testing in the evaluation of hypothyroidism. Approximately 2/3 of all respondents indicated that they would treat patients with mild thyroid failure when antithyroid antibodies are negative; 77% of PCPs and 95% of ATA members recommended treatment when antibodies are positive. For a young patient with mild thyroid failure, 71% of ATA members would initiate a full levothyroxine (LT4) replacement dose of 1.6 microg/kg per day or slightly lower; PCPs were more likely to start with a low dose and titrate upwards. For a young patient with overt hypothyroidism, 42% of PCPs and 51% of ATA respondents recommended an initial full LT4 replacement dose. The majority of all respondents would start with a low LT4 dose and adjust the dose gradually in an elderly patient, regardless of the severity of thyroid hormone deficiency. More than 40% of ATA respondents chose a target thyrotropin (TSH) range of 0.5-2.0 microU/mL for a young patient while 39% favored a goal of 1.0-4.0 microU/mL for an elderly patient. PCPs more often chose a broader TSH goal of 0.5-5.0 microU/mL. In conclusion, the current practice patterns of PCPs and ATA members that were elicited in this survey differ significantly in regard to the evaluation and management of hypothyroidism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1050-7256
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
757-64
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:11525268-Adult,
pubmed-meshheading:11525268-Aged,
pubmed-meshheading:11525268-Aged, 80 and over,
pubmed-meshheading:11525268-Autoantibodies,
pubmed-meshheading:11525268-Data Collection,
pubmed-meshheading:11525268-Dose-Response Relationship, Drug,
pubmed-meshheading:11525268-Female,
pubmed-meshheading:11525268-Humans,
pubmed-meshheading:11525268-Hypothyroidism,
pubmed-meshheading:11525268-Male,
pubmed-meshheading:11525268-Medicine,
pubmed-meshheading:11525268-Middle Aged,
pubmed-meshheading:11525268-Patient Care Management,
pubmed-meshheading:11525268-Primary Health Care,
pubmed-meshheading:11525268-Specialization,
pubmed-meshheading:11525268-Thyroid Gland,
pubmed-meshheading:11525268-Thyrotropin,
pubmed-meshheading:11525268-Thyroxine
|
pubmed:year |
2001
|
pubmed:articleTitle |
Management practices among primary care physicians and thyroid specialists in the care of hypothyroid patients.
|
pubmed:affiliation |
Division of Endocrinology, Metabolism & Diabetes, University of Colorado Health Sciences Center, Denver 80262, USA. michael.mcdermott@uchsc.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|